A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy - 24/08/11
Reprint requests: Jeff E. Mandel, MD, MS, Department of Anesthesiology & Critical Care, 780 B Dulles Building, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104.Résumé |
Background |
Patient-controlled sedation (PCS) with propofol-remifentanil (PR) is associated with rapid sedation and recovery, but it is associated with a greater requirement for airway rescue than PCS with midazolam-fentanyl.
Objective |
To demonstrate that respiratory depression associated with PR is more frequent during anesthesiologist-administered sedation (AAS) than during PCS.
Design |
Prospective, randomized, open-label study.
Setting |
Academic medical center.
Patients |
Fifty patients undergoing elective colonoscopy.
Intervention |
PCS or AAS using PR. All patients breathed 100% oxygen via an anesthesia mask with continuous spirometry and bispectral index (BIS).
Main Outcome Measurements |
Respiratory rate and BIS.
Results |
Colonoscopy was completed in all patients. No patient under PCS required airway rescue. Five patients under AAS required bag-mask ventilation to resolve Sao2 (arterial oxygen saturation) less than 90% lasting longer than 30 seconds. The median BIS for the AAS group was 71.7 (range 61.06-82.34) and 88.1 (range 83.15-93.05) for the PCS group. Median respiratory rates were 5.97 (range 1.21–10.73) breaths per minute for AAS and 13.19 (range 9.54–16.84) for PCS. Respiratory rates less than 2 breaths per minute composed 28% of the procedure time for AAS, but only 5% for PCS. Patients under PCS had lower median predicted effect site concentrations for PR, but were able to achieve brief peak levels exceeding those with AAS. These differences were significant (P < .001).
Limitations |
Potential for bias with AAS.
Conclusions |
Patients undergoing colonoscopy with PR are significantly more likely to require intervention for hypoventilation compared with PCS. (Clinical trial registration number:NCT00868920.)
Le texte complet de cet article est disponible en PDF.Abbreviations : AAS, BIS, PCS, PMS, PR
Plan
| DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: J.E. Mandel: Speaker for Bioniche Pharma. G.R. Lichtenstein: Advisory committee and lecture funding: Consultant: Abbott Laboratories. M.L. Kochman: Spouse: stock and executive: Merck. |
Vol 72 - N° 1
P. 112-117 - juillet 2010 Retour au numéro
Article précédent
- Achieving complete small-bowel capsule endoscopy: is it possible and does it matter?
- Felice Schnoll-Sussman
- Meshed capillary vessels found on narrow-band imaging without optical magnification effectively identifies colorectal neoplasia: a North American validation of the Japanese experience
- Zachary H. Henry, Paul Yeaton, Vanessa M. Shami, Michel Kahaleh, James T. Patrie, Dawn G. Cox, David A. Peura, Fabian Emura, Andrew Y. Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?